Torthaí cuardaigh - Nimer Assy

  • 1 - 15 toradh as 15 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Vitamin D improves viral response in hepatitis C genotype 2-3 naïve patients

    Vitamin D improves viral response in hepatitis C genotype 2-3 naïve patients de réir Nimer Assy

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Vitamin D improves viral response in hepatitis C genotype 2-3 naïve patients

    Vitamin D improves viral response in hepatitis C genotype 2-3 naïve patients de réir Nimer, Assy, Mouch, Abu

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán
    Téacs
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Olive oil consumption and non-alcoholic fatty liver disease

    Olive oil consumption and non-alcoholic fatty liver disease de réir Nimer Assy, Faris Nassar, Gattas Nasser, Maria Grosovski

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Relationship between Retinal Vascular Caliber and Coronary Artery Disease in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)

    Relationship between Retinal Vascular Caliber and Coronary Artery Disease in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) de réir Josef, Pikkel, Ali, Ibrahim, Ariel, Prober, Alon, Marmor, Nimer, Assy

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán
    Téacs
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Characteristics of common solid liver lesions and recommendations for diagnostic workup

    Characteristics of common solid liver lesions and recommendations for diagnostic workup de réir Nimer Assy, Gattas Nasser, A. Djibre, Zaza Beniashvili, Elias Saad, Jamal Zidan

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Soft Drink Consumption Linked with Fatty Liver in the Absence of Traditional Risk Factors

    Soft Drink Consumption Linked with Fatty Liver in the Absence of Traditional Risk Factors de réir Nimer Assy, Gattas Nasser, Iad Kamayse, William Nseir, Zaza Beniashvili, A. Djibre, Maria Grosovski

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Hidden in the Fat: Unpacking the Metabolic Tango Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Syndrome

    Hidden in the Fat: Unpacking the Metabolic Tango Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Syndrome de réir Mariana Boulos, Rabia S. Mousa, Nizar Jeries, Elias Simaan, K.S. Alam, Bulus Bulus, Nimer Assy

    Foilsithe / Cruthaithe 2025
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Randomized Controlled Trial of Total Immunosuppression Withdrawal in Liver Transplant Recipients: Role of Ursodeoxycholic Acid

    Randomized Controlled Trial of Total Immunosuppression Withdrawal in Liver Transplant Recipients: Role of Ursodeoxycholic Acid de réir Nimer Assy, Paul C. Adams, Paul R. Myers, Verra Simon, Gerry Y. Minuk, William Wall, Cameron N. Ghent

    Foilsithe / Cruthaithe 2007
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Role of illness perception and self-efficacy in lifestyle modification among non-alcoholic fatty liver disease patients

    Role of illness perception and self-efficacy in lifestyle modification among non-alcoholic fatty liver disease patients de réir Shira Zelber‐Sagi, Shiran Bord, Gali Dror-Lavi, Matthew Lee Smith, Samuel D. Towne, Assaf Buch, Muriel Webb, Hanny Yeshua, Nimer Assy, Oren Shibolet

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Role of illness perception and self-efficacy in lifestyle modification among non-alcoholic fatty liver disease patients

    Role of illness perception and self-efficacy in lifestyle modification among non-alcoholic fatty liver disease patients de réir Zelber-Sagi, Shira, Bord, Shiran, Dror-Lavi, Gali, Smith, Matthew Lee, Towne Jr, Samuel D, Buch, Assaf, Webb, Muriel, Yeshua, Hanny, Nimer, Assy, Shibolet, Oren

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán
    Téacs
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Antibody Repertoire Analysis of Hepatitis C Virus Infections Identifies Immune Signatures Associated With Spontaneous Clearance

    Antibody Repertoire Analysis of Hepatitis C Virus Infections Identifies Immune Signatures Associated With Spontaneous Clearance de réir Eliyahu, Sivan, Sharabi, Oz, Elmedvi, Shiri, Timor, Reut, Davidovich, Ateret, Vigneault, Francois, Clouser, Chris, Hope, Ronen, Nimer, Assy, Braun, Marius, Weiss, Yaacov Y., Polak, Pazit, Yaari, Gur, Gal-Tanamy, Meital

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán
    Téacs
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals

    Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals de réir Shira Perez, Antony Kaspi, Tom Domovitz, Ateret Davidovich, Anat Lavi-Itzkovitz, Tomer Meirson, Jacinta A. Holmes, Chia‐Yen Dai, Chung‐Feng Huang, Raymond T. Chung, Nimer Assy, Assam El‐Osta, Gur Yaari, Salomon M. Stemmer, Ming‐Lung Yu, Izhak Haviv, Meital Gal-Tanamy

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals

    Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals de réir Perez, Shira, Kaspi, Antony, Domovitz, Tom, Davidovich, Ateret, Lavi-Itzkovitz, Anat, Meirson, Tomer, Alison Holmes, Jacinta, Dai, Chia-Yen, Huang, Chung-Feng, Chung, Raymond T., Nimer, Assy, El-Osta, Assam, Yaari, Gur, Stemmer, Salomon M., Yu, Ming-Lung, Haviv, Izhak, Gal-Tanamy, Meital

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán
    Téacs
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Effect of Opaganib on Supplemental Oxygen and Mortality in Patients with Severe SARS-CoV-2 Pneumonia

    Effect of Opaganib on Supplemental Oxygen and Mortality in Patients with Severe SARS-CoV-2 Pneumonia de réir Fernando Carvalho Neuenschwander, Ofra Barnett‐Griness, Stefania Piconi, ‪Yasmin Maor‬‏, Eduardo Sprinz, Nimer Assy, Oleg Khmelnitskiy, N. V. Lomakin, Boris Mikhailovich Goloshchekin, Ewelina Nahorecka, Adilson Joaquim Westheimer Calvacante, Anastasia Ivanova, S. V. Zhuravel, Galina Yurevna Trufanova, Stefano Bonora, Amer Saffoury, Ami Mayo, Yu. G. Shvarts, Giuliano Rizzardini, Rogério Sobroza de Mello, Janaina Pilau, Alexey Klinov, Benjamín Valente-Acosta, Oleg O. Burlaka, Natalia A. Bakhtina, Maskit Bar‐Meir, Ivan Shishimorov, Jose Oñate-Gutierrez, Cristian Iván García Rincón, Tatiana Martynenko, Ludhmila Abrahão Hajjar, Ana Carolina Nazare de Mendonca Procopio, Krzystof Simon, Walter Gabriel Chaves, Adam Fronczak, Conrado Roberto Hoffmann Filho, Osama Hussein, Vladimir Aleksandrovich Martynov, Guido Chichino, Piotr Blewaska, Jacek Wróblewski, Sergio Saul Irizar Santana, Andres Felipe Ocampo Agudelo, Adam Barczyk, Rachael L. Gerlach, Eppie Campbell, Aida Bibliowicz, Reza Fathi, Patricia J. Anderson, Gilead Raday, Michal Klein, Clara Fehrmann, Gina Eagle, Vered Katz Ben-Yair, Mark L. Levitt

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Pré-impressão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Effect of Opaganib on Supplemental Oxygen and Mortality in Patients with Severe SARS-CoV-2 Based upon FIO2 Requirements

    Effect of Opaganib on Supplemental Oxygen and Mortality in Patients with Severe SARS-CoV-2 Based upon FIO2 Requirements de réir Fernando Carvalho Neuenschwander, Ofra Barnett‐Griness, Stefania Piconi, ‪Yasmin Maor‬‏, Eduardo Sprinz, Nimer Assy, Oleg Khmelnitskiy, N. V. Lomakin, Boris Mikhailovich Goloshchekin, Ewelina Nahorecka, Adilson Joaquim Westheimer Calvacante, Anastasia Ivanova, S. V. Zhuravel, Galina Yurevna Trufanova, Stefano Bonora, Amer Saffoury, Ami Mayo, Yu. G. Shvarts, Giuliano Rizzardini, Rogério Sobroza de Mello, Janaina Pilau, Alexey Klinov, Benjamín Valente-Acosta, Oleg O. Burlaka, Natalia A. Bakhtina, Maskit Bar‐Meir, Ivan Shishimorov, Jose Oñate-Gutierrez, Cristian Iván García Rincón, Tatiana Martynenko, Ludhmila Abrahão Hajjar, Ana Carolina Nazare de Mendonca Procopio, Krzysztof Simon, Walter Gabriel Chaves, Adam Fronczak, Conrado Roberto Hoffmann Filho, Osama Hussein, В. А. Мартынов, Guido Chichino, Piotr Blewaska, Jacek Wróblewski, Sergio Saul Irizar Santana, Andres Felipe Ocampo Agudelo, Adam Barczyk, Rachael L. Gerlach, Eppie Campbell, Aida Bibliowicz, Reza Fathi, Patricia J. Anderson, Gilead Raday, Michal Klein, Clara Fehrmann, Gina Eagle, Vered Katz Ben-Yair, Mark L. Levitt

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: